Article Text
Editorial
High-flow nasal oxygen: benefits are hard to show in COVID-19 patients with mild hypoxaemia
Statistics from Altmetric.com
Footnotes
Contributors AWT and J-PF wrote the editorial.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests AWT and J-PF received grants, non-financial supports and personnal fees (travel expense coverage to attend scientific meetings and payments for lectures) from Fisher & Paykel.
Provenance and peer review Commissioned; externally peer reviewed.